US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
SymBio Pharmaceuticals Ltd (PK) (SYMQY) 銘柄情報

SymBio Pharmaceuticals Ltd (PK) (SYMQY)

0.5579

0.00

(0.00%)

終了 7月8日 5:00AM

SymBio Pharmaceuticals Ltd (PK) (SYMQY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.5579

( - )

買値

0.3659

売値

56,400.53

出来高

-

平均取引量 (3 か月)

US$ 816,700

財務取引量

-

0.00 日の範囲 0.00

0.5579 52 週間の範囲 1.1944

時価総額

企業価値

4.685B

前日終値

0.5579

始値

-

時刻

最終取引時間

VWAP

-

歳入

1.28B

純利益

-5.86B

発行済株式数

72,147,741

浮動株比率 (%)

96.21%

機関投資家保有比率 (%)

0.53%

配当利回り

PER

-0.72

株価売上高倍率 (PSR)

4.35

1 株当たり利益 (EPS)

-106.24

ベータ

0.49

SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases;... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.symbiopharma.com

本社

Minato, Japan

設立

2026

SymBio Pharmaceuticals Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker SYMQY. The last closing price for SymBio Pharmaceuticals (PK) was US$0.56. Over the last year, SymBio Pharmaceuticals (PK) shares have traded in a share price range of US$ 0.5579 to US$ 1.1944.

SymBio Pharmaceuticals (PK) currently has 72,147,741 shares in issue. The market capitalisation of SymBio Pharmaceuticals (PK) is US$40.25 million. SymBio Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of -0.72.

EDISON EQUITY RESEARCH: SYMBIO PHARMACEUTICALS

EDISON EQUITY RESEARCH: SYMBIO PHARMACEUTICALS - WITH EXPERIENCE COMES CONFIDENCEThree steps forward, one step back. With the December filing of...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0.5579	0.5579	0.5579	0	0	DR
26	-0.0791	-12.4175824176	0.637	0.637	0.5579	143	0.5579	DR
52	-0.6365	-53.29035499	1.1944	1.1944	0.5579	1388	0.87167841	DR
156	-2.3521	-80.8281786942	2.91	2.91	0.5579	1169	0.96028601	DR
260	-1.8921	-77.2285714286	2.45	6.98	0.5579	955	1.12182041	DR

SYMQY - Frequently Asked Questions (FAQ)

What is the current SymBio Pharmaceuticals Ltd (PK) share price?

The current share price of SymBio Pharmaceuticals Ltd (PK) is US$ 0.5579

How many SymBio Pharmaceuticals Ltd (PK) shares are in issue?

SymBio Pharmaceuticals Ltd (PK) has 72,147,741 shares in issue

What is the market cap of SymBio Pharmaceuticals Ltd (PK)?

The market capitalisation of SymBio Pharmaceuticals Ltd (PK) is USD 40.25M

What is the 1 year trading range for SymBio Pharmaceuticals Ltd (PK) share price?

SymBio Pharmaceuticals Ltd (PK) has traded in the range of US$ 0.5579 to US$ 1.1944 during the past year

What is the PE ratio of SymBio Pharmaceuticals Ltd (PK)?

The price to earnings ratio of SymBio Pharmaceuticals Ltd (PK) is -0.72

What is the cash to sales ratio of SymBio Pharmaceuticals Ltd (PK)?

The cash to sales ratio of SymBio Pharmaceuticals Ltd (PK) is 4.35

What is the registered address of SymBio Pharmaceuticals Ltd (PK)?

The registered address for SymBio Pharmaceuticals Ltd (PK) is Toranomon Towers Office, Minato, Tokyo, 105-0001

What is the SymBio Pharmaceuticals Ltd (PK) website address?

The website address for SymBio Pharmaceuticals Ltd (PK) is www.symbiopharma.com

Which industry sector does SymBio Pharmaceuticals Ltd (PK) operate in?

SymBio Pharmaceuticals Ltd (PK) operates in the Pharmaceuticals sector

splintered sunlight

splintered sunlight 4分前

Exactly

Same bullchit.......

splintered sunlight

splintered sunlight 5分前

splintered sunlight

splintered sunlight 7分前

Hopefully yes!!!!

satter

And what do you think is the reason for this? This is a direct compliance reaction to the severe leaks exposed in the July 1st Florida courtroom. Under cross-examination, Hiru's records custodian ( Roxanna Green ) admitted that 515,000,000 shares were issued to their internal accountant with zero i

JJ24

I haven’t been able to speak to Chris in almost a year . To be honest I don’t think he tried to fuk us all . He just got in bed with the wrong company . Nostrum fuked it all up .

Oleblue

Oleblue 9分前

This Quantum Stock Could 4X if Wall Street Wakes Up | My $43 Price Target

https://youtu.be/-o77wrf84W4

Daily Chart
https://schrts.co/qJZFfTGc

chuck1418

chuck1418 9分前

we need more volume then we really take off. people will see the low later and it will run

Gangbang At Huggys

Gangbang At Huggys 10分前

Hows your grandkids assholes? Round 2?

Kool Aid Man

Kool Aid Man 11分前

"Engaging Auditors"=cheap Scamming 101 playbook. Guess who also just "engaged VMCPA" on 5/22/2026...

ROXANNA LOU GREEN

LMFAO!!!

CHRIST ON A CRUTCH!!! Her HW*AL scam is flashing an OTC >>YIELD WARING

splintered sunlight

splintered sunlight 11分前

Gangbang At Huggys

Gangbang At Huggys 11分前

Wow, look at all these 75 year old faggots that love molesting their grandkids

splintered sunlight

splintered sunlight 11分前

If BCBC went up a penny every time you posted about it, it would be well over $2!!!!!!!!!!!!!!!

yanevano

yanevano 12分前

About 3 months ago. Some kind of cancer. His brother posted it on Facebook.

81vette

81vette 13分前

I am on a beautiful white sparkling quartz sand beach on the north coast (upper Michigan on Lake Superior) 72 degrees day high,swimming in the cool water. Watching the northern lights at night, waiting for EDGM to break out over .10 before end of July

FrostyStar1

FrostyStar1 15分前

So you have no sources and nothing else except nonsense.

You said Mark Bolster didn't make money. He stole the investors money.

He could have easily bought shares and sold them manipulating the market.

You dont know what you are talking about.

zerosnoop

zerosnoop 15分前

OPERATIONAL EFFICIENCIES
CONFIGURABLE TO CUSTOMER SPECIFICATIONS

Through significant reductions in viscosity, AOT has effected a revolution in how we manage hydrocarbon pipelines.

And into the loading and unloading of tankers, trains and trucks, the revolution ha

PEMBROKE1

PEMBROKE1 15分前

Maybe most people know about this.
I thought it is interesting.
All done in less than a month

Corporate Actions

Action Type Effective Date Symbol Description
Market Change 05/08/2026 MBAK Market change from OTCID to Pink Limited
Market Change

splintered sunlight

splintered sunlight 16分前

ironhammer

ironhammer 16分前

thanks for the DD

maumar

maumar 16分前

Wow! Are you serious? The XBI is up 96% from a year ago! Many biotechs have doubled multiple times in the past twelve months! My point was that there have been much better opportunities out there than buying Halo at those prices. And that is obviously true!

And what about my last post

mailman69

mailman69 16分前

How can the owner make money off the company that only happens if the owner is selling shares of the stock and pocketing that money that did not happen here

Chartmaster

Chartmaster 19分前

Charts helped me make bank like 3-4 times here so far and on the same numbers going up, charts allowed me to make triple, some people just aren't that sharp to even try trading with charts, SMH

mailman69

mailman69 19分前

Any shares bought in the Open market, the arm makes more money offer

OracleWitch66

OracleWitch66 19分前

Looks like we r start n to get more attention. #4 on bob

SymBio Pharmaceuticals (PK)

iShares JP Morgan Advanc...

WTB Financial (ID)

Strategic Streaming and ...

Alicanto Minerals

Flagstar Bank NA

Eqty Lkd Nts 09/07/26

Green Technology Metals

Gold Reserve (QX)

Vision Sensing Acquisition

Pegasus Resources

NuGen Medical Devices (PK)

Bank of New York Mellon

Hsbc Icav Cn Go

Franklin Global Core

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。